Cataract surgery complications: An in vitro model of toxic effects of Ropivacaine and lidocaine

Nicola Pescosolido, Gianfranco Scarsella, Marco Tafani, Marcella Nebbioso

Research output: Contribution to journalArticlepeer-review


Background: Intraoperative lidocaine is widely used in controlling discomfort during cataract surgery. However, recent studies have confirmed the toxic effect of lidocaine on ganglion cells. Ropivacaine is an anesthetic recently introduced in clinical practice that couples a long anesthetic effect with a mild vasoconstrictive action. Objective: The aim of this study was an in vitro evaluation of the efficacy of ropivacaine in reducing the degenerative effects usually observed during lidocaine treatment. Methods: Ropivacaine and lidocaine toxicity has been evaluated in murine fibroblasts 3T6 by measuring percentage of cell death, cell growth inhibition, and DNA degradation. The choice of this cellular line is motivated by the presence of a complete apoptotic system that can be assimilated to the endothelium precursor cells. Results: We observed that lidocaine 0.25% decreases cell viability and causes DNA degradation in murine fibroblasts 3T6, whereas ropivacaine 0.5% does not cause any cellular or molecular degenerative effect. Conclusions: Our in vitro studies confirm that ropivacaine is less toxic than lidocaine to these cells. Therefore, in vivo studies in the anterior chamber could be useful to evaluate the effects of ropivacaine versus lidocaine in intracameral anesthesia in cataract surgery.

Original languageEnglish
Pages (from-to)303-307
Number of pages5
JournalDrugs in R and D
Issue number4
Publication statusPublished - 2011

ASJC Scopus subject areas

  • Pharmacology


Dive into the research topics of 'Cataract surgery complications: An in vitro model of toxic effects of Ropivacaine and lidocaine'. Together they form a unique fingerprint.

Cite this